SARTORIUS STED BIO (EPA:DIM) | WebDisclosure

Basculer en Français

8677	Companies
149367	Keywords
84978	Articles
80092	Press releases

Home
Companies
SARTORIUS STED BIO

BRIEF

published on 05/05/2025 at 12:20, 17 days 21 hours ago

Publication of the number of shares and voting rights of Sartorius Stedim Biotech

Share Capital Voting Rights Actions Sartorius Stedim Biotech Regulatory Information
BRIEF

published on 05/05/2025 at 12:20, 17 days 21 hours ago

Publication du nombre d'actions et droits de vote de Sartorius Stedim Biotech

Droits De Vote Capital Social Actions Sartorius Stedim Biotech Informations Réglementaires
PRESS RELEASE

published on 05/05/2025 at 12:15, 17 days 21 hours ago

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA makes declaration on number of shares and voting rights in the issued capital, meeting regulatory requirements. Details in the announcement

Voting Rights Déclaration Shares Sartorius Stedim Biotech Regulatory Requirements
PRESS RELEASE

published on 05/05/2025 at 12:15, 17 days 21 hours ago

Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
Communiqué de Sartorius Stedim Biotech SA sur la déclaration du nombre d'actions et de droits de vote. Informations réglementaires transmises par EQS Group

Déclaration Droits De Vote Actions EQS Group Sartorius Stedim Biotech
BRIEF

published on 04/16/2025 at 14:46, 1 month 6 days ago

Résultats du Premier Trimestre 2025 de Sartorius Stedim Biotech

Chiffre D'affaires EBITDA Sartorius Stedim Biotech 2025 Prévisions Bioproduction
BRIEF

published on 04/16/2025 at 14:46, 1 month 6 days ago

Sartorius Stedim Biotech First Quarter 2025 Results

EBITDA Sartorius Stedim Biotech Turnover 2025 Forecast Bioproduction
PRESS RELEASE

published on 04/16/2025 at 14:41, 1 month 6 days ago

Sartorius Stedim Biotech publie ses résultats non audités pour le premier trimestre 2025
Sartorius Stedim Biotech publie des résultats solides pour le premier trimestre 2025 avec une croissance à deux chiffres du chiffre d'affaires et une augmentation de l'EBITDA courant

Résultats Financiers Croissance EBITDA Sartorius Stedim Biotech Bioproduction
BRIEF

published on 04/16/2025 at 07:05, 1 month 7 days ago

Sartorius Stedim Biotech Reports Q1 2025 Results with Strong Growth

Financial Performance Profitability Biotech Growth Q1 2025 Results Biomanufacturing Demand
BRIEF

published on 04/16/2025 at 07:05, 1 month 7 days ago

Sartorius Stedim Biotech annonce une forte croissance de ses résultats du premier trimestre 2025

Rentabilité Performance Financière Croissance De La Biotechnologie Résultats Du Premier Trimestre 2025 Demande De Biofabrication
PRESS RELEASE

published on 04/16/2025 at 07:00, 1 month 7 days ago

Sartorius Stedim Biotech publie ses résultats non audités pour le premier trimestre 2025
Sartorius Stedim Biotech publie ses résultats non audités pour le premier trimestre 2025, avec une croissance du chiffre d'affaires à deux chiffres et des prévisions optimistes pour l'année en cours

Chiffre D'affaires Croissance Sartorius Stedim Biotech Résultat Trimestriel Prévision

Accesswire

Published on 05/23/2025 at 09:05, 48 minutes ago

BioNxt Solutions Reports Formal Notice from the European Patent Office of Intention to Grant Patent
Published on 05/23/2025 at 00:00, 9 hours 53 minutes ago

Onco-Innovations Announces Appointment of Professor Steven Jones as Senior Scientific Advisor, Strengthening Technical Acumen in AI-Powered Precision Oncology
Published on 05/22/2025 at 23:00, 10 hours 53 minutes ago

Cerrado Gold Announces First Quarter Financial Results Release Date and Conference Call
Published on 05/22/2025 at 23:00, 10 hours 53 minutes ago

D. Boral Capital acted as Exclusive Placement Agent to Luminar Technologies (NASDAQ:LAZR) in connection with its up to $200.0 Million Equity Linked Securities Offering
Published on 05/22/2025 at 22:15, 11 hours 38 minutes ago

Kingstone Successfully Sponsors Inaugural $125 Million Catastrophe Bond

View all ACCESSWIRE

EQS Group

Published on 05/23/2025 at 09:00, 53 minutes ago

Original-Research: NFON AG (von NuWays AG): BUY
Published on 05/23/2025 at 09:00, 53 minutes ago

Brödernas Group AB (publ) delays the publication of the annual audited consolidated financial statements of the Group due in April 2025
Published on 05/23/2025 at 09:00, 53 minutes ago

Alzchem Group AG successfully completes long-term succession planning for its Management Board: Supervisory Board appoints Dr. Jürgen Sans as Chief Operating Officer with effect from 1 January 2026
Published on 05/23/2025 at 09:00, 53 minutes ago

Secarna Pharmaceuticals to present new data and clinical strategy for lead antisense oligonucleotide program SECN-15 at ASCO 2025
Published on 05/23/2025 at 08:58, 55 minutes ago

Grand City Properties S.A. announces publication of convening notice for the 2025 Annual General Meeting

Les Echos

Published on 05/23/2025 at 08:00, 1 hour 53 minutes ago

KLARSEN : Initiation de couverture de la valeur par CHAMPEIL SA
Published on 05/23/2025 at 07:30, 2 hours 23 minutes ago

Vif succès de l’augmentation de capital de NFL Biosciences avec une levée plafonnée à 3 millions d’euros
Published on 05/23/2025 at 07:30, 2 hours 23 minutes ago

NFL Biosciences announces the success of its capital increase capped at €3 million
Published on 05/22/2025 at 18:00, 15 hours 53 minutes ago

ICADE – CP – SUCCÈS DE L’OFFRE DE RACHAT OBLIGATAIRE POUR UN MONTANT DE 265 M€
Published on 05/22/2025 at 18:00, 15 hours 53 minutes ago

ICADE – PR – SUCCESS OF THE CASH TENDER OFFER FOR A TOTAL AMOUNT OF €265 MILLION

View all LES ECHOS COMFI WIRE